MedPath

The Effect of Honey on Xerostomia and Oral Mucositis

Phase 2
Completed
Conditions
Head and Neck Cancer
Interventions
Other: Normal Saline
Dietary Supplement: Honey mouthwash
Registration Number
NCT01465308
Lead Sponsor
Cyprus University of Technology
Brief Summary

The purpose of this study is to determine whether the use of pure honey will help in the treatment of radiation induced xerostomia and oral mucositis (symptom management)

Detailed Description

Radiation-induced mucositis is a normal acute side effect of radiotherapy treatment. Exposure of ionising radiation to oral, pharyngeal and laryngeal mucosa gives rise to radiation epithelitis towards the second and third weeks of conventional fractionated radiotherapy. Likewise, salivary flow may decrease by approximately 50% during the first week of radiotherapy and upwards of 80% by the seventh week of treatment. Acute radiation-induced xerostomia is associated with inflammatory reaction. The study will include an intervention and a control group, one receiving honey prior and after the radiotherapy and the other group not receiving honey at all.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
72
Inclusion Criteria
  • Patients who receive radiotherapy (RT) to the oral cavity will be included in the study.
  • Patients with a confirmed histologic diagnosis of head and neck cancer referred to non-palliative radiotherapy will enter into this trial.
  • aged over 18
  • receiving radiotherapy for at least four weeks
Exclusion Criteria
  • Allergic to honey
  • confirmed and medically treated diabetes mellitus

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Saline mouthwashNormal SalineThe patients in this group will receive saline rinses
receiving HoneyHoney mouthwashThe patients will receive honey mouthwash rinses
Primary Outcome Measures
NameTimeMethod
Change from baseline in Xerostomia grades1 week, 2 weeks, 3 weeks, 4 weeks
Change from baseline in oral mucositis grades1 week, 2 weeks, 3 weeks, 4 weeks
Secondary Outcome Measures
NameTimeMethod
Changes in the General satisfaction of comfort1 week, 2 week, 3 week, 4 week
Change in baseline weight in one month4 weeks

Trial Locations

Locations (1)

Bank of Cyprus Oncology Centre

🇨🇾

Nicosia, Cyprus

© Copyright 2025. All Rights Reserved by MedPath